explore -WSS

explore

author：explore 2025-10-04 05:11:44 - browse：843

Adobe

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday.

The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology. Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

An insulin pump shutting down unexpectedly could kill people, especially if the shutdown occurs while the person is sleeping. There have been no reports of death so far, the FDA said. Tandem users commiserated over the issue on Reddit two months ago, with one user describing waking up at 2 a.m. to a dead pump. “Infuriating,” the user wrote. “Absolutely should be sending a notice out to all customers about this.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Readout Newsletter: New research from Sanofi, Regeneron, etc.

WSS

Maisha Meds is a PBM, but don't call it that

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Telehealth options flood the market as retailers push virtual care

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Pumping milk in bathrooms at health conferences is common

Future doctors need a strong humanities education

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Supreme Court strikes down use of affirmative action

The pink breast cancer awareness ribbon needs a redesign

Novavax promises a turnaround & Lilly roils the obesity market

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Walensky prepares to leave CDC — and Congress — behind

Printout prescription drug information shouldn’t go digital

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

hotspot

To bolster infectious disease surveillance, genomics powerhouses team up

There's an unseen cost to disruptive road

WHO may add ‘noma' to its list of neglected tropical diseases

Medtronic CEO on promising devices for diabetes, hypertension

Emergency medicine has repudiated 'excited delirium.' Now what?

Medicare bonuses could stop drug shortages under Senate plan

focus

hotspot

Wikipedia

leisure time